GlaxoSmithKline, Vir Biotech Say COVID Therapy Works On Omicron - TheStreet

Retrieved on: 2021-12-07 12:06:01

Tags for this article:

Coronaviridae

Variants of SARS-CoV-2

Viruses

Virology

COVID-19 drug development

Sotrovimab

COVID-19 pandemic in South Africa

SARS-CoV-2 Omicron variant

SARS-CoV-2 Delta variant

Variant of concern

Coronavirus spike protein

SARS-CoV-2 Mu variant

Vir Biotechnology

GlaxoSmithKline plc

Click the tags to see associated articles and topics

GlaxoSmithKline, Vir Biotech Say COVID Therapy Works On Omicron - TheStreet. View article details on HISWAI: https://www.thestreet.com/markets/glaxosmithkline-vir-biotech-say-covid-therapy-works-on-omicron

Excerpt

GlaxoSmithKline and its U.S. partner, Vir Biotechnology, said Tuesday that their COVID antibody is effective against all mutations of the new ...

Article found on: www.thestreet.com

View Original Article